top of page
News
Chat
Analysis
Education
About
Pricing
BPIQ API
BPIQ Blog
Dec 9, 2019
3 min read
Merck acuires Arqule: Non-covalent Btk kinase inhibitors take center stage
Merck (MRK.N) reported today that it is buying ARQL for over a 100% premium from Friday's closing price (https://reut.rs/341eQv1). This...
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
